Prophylactic somatostatin can reduce incidence of post-ERCP pancreatitis: Multicenter randomized controlled trial

Endoscopy

Volumn 75, Issue , 2015, Pages 415-420

  Bai, Yu ^a   Ren, Xu ^b   Zhang, Xiao Feng ^c   Lv, Nong Hua ^d   Guo, Xue Gang ^e   Wan, Xin Jian ^f   Nie, Zhan Guo ^g   Han, Shu Tang ^h   Bie, Ping ⁱ   Tian, De An ^j   Ji, Ming ^k   Li, Zhao Shen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Heilongjiang Province Hospital   (China)

^c HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^d NANCHANG UNIVERSITY   (China)

^e FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^f SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^g LANZHOU GENERAL HOSPITAL   (China)

^h AFFILIATED HOSPITAL OF NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

ⁱ THIRD MILITARY MEDICAL UNIVERSITY   (China)

^j HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^k CAPITAL MEDICAL UNIVERSITY   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; CONTRAST MEDIUM; SOMATOSTATIN; HORMONE;

ABDOMINAL PAIN; ADULT; AGED; AMYLASE BLOOD LEVEL; ARTICLE; BOLUS INJECTION; CONFIDENCE INTERVAL; CONTINUOUS INFUSION; CONTROLLED STUDY; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FATTY ACID DESATURATION; FEMALE; HEART PALPITATION; HUMAN; HYPERAMYLASEMIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; OPEN STUDY; PANCREAS DISEASE; PANCREATITIS; PARESTHESIA; POST ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY PANCREATITIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SURGICAL RISK; TREATMENT OUTCOME; UPPER GASTROINTESTINAL BLEEDING; VOMITING; ADVERSE EFFECTS; BLOOD; CLINICAL TRIAL; VERY ELDERLY; YOUNG ADULT; CHINA; OUTCOME ASSESSMENT; SIDE EFFECT; TERTIARY CARE CENTER;

ADULT; AGED; AGED, 80 AND OVER; AMYLASES; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; FEMALE; HORMONES; HUMANS; HYPERAMYLASEMIA; MALE; MIDDLE AGED; PANCREATITIS; SOMATOSTATIN; YOUNG ADULT;

EID: 84928559138     PISSN: 0013726X     EISSN: 14388812     Source Type: Journal    
DOI: 10.1055/s-0034-1391227     Document Type: Article

References (33)

1. Anderson MA, Fisher L. ASGE Standards of Practice Committee. et al. Complications of ERCP. Gastrointest Endosc 2012; 75: 467-473
2. Andriulli A, Loperfido S, Napolitano G et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol 2007; 102: 1781-1788
3. Wang P, Li ZS, Liu F et al. Risk factors for ERCP-related complications: a prospective multicenter study. Am J Gastroenterol 2009; 104: 31-40
4. Bai Y, Gao J, Zhang W et al. Meta-analysis: allopurinol in the prevention of postendoscopic retrograde cholangiopancreatography pancreatitis. Aliment Pharmacol Ther 2008; 28: 557-564
5. Bai Y, Gao J, Shi X et al. Prophylactic corticosteroids do not prevent post-ERCP pancreatitis: a meta-analysis of randomized controlled trials. Pancreatology 2008; 8: 504-509
6. Bai Y, Gao J, Zou DW et al. Prophylactic octreotide administration does not prevent post-endoscopic retrograde cholangiopancreatography pancreatitis: ameta-analysis of randomized controlled trials. Pancreas 2008; 37: 241-246
7. Elmunzer BJ, Scheiman JM, Lehman GA et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med 2012; 366: 1414-1422
8. Choudhary A, Bechtold ML, Arif M et al. Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review. Gastrointest Endosc 2011; 73: 275-282
9. Freeman ML. Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol 2007; 5: 1354-1365
10. Bordas JM, Toledo-Pimentel V, Llach J et al. Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography: results of a randomized study. Gastrointest Endosc 1998; 47: 230-234
11. Lee KT, Lee DH, Yoo BM. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial. Pancreas 2008; 37: 445-448
12. Andriulli A, Clemente R, Solmi L et al. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial. Gastrointest Endosc 2002; 56: 488-495
13. Andriulli A, Solmi L, Loperfido S et al. Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate. Clin Gastroenterol Hepatol 2004; 2: 713-718
14. Omata F, Deshpande G, Tokuda Y et al. Meta-analysis: somatostatin or its long-acting analogue, octreotide, for prophylaxis against post-ERCP pancreatitis. J Gastroenterol 2010; 45: 885-895
15. Andriulli A, Leandro G, Federici T et al. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis. Gastrointest Endosc 2007; 65: 624-632
16. Cotton PB, Lehman G, Vennes J et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991; 37: 383-393
17. Moffatt DC, Coté GA, Avula H et al. Risk factors for ERCP-related complications in patients with pancreas divisum: a retrospective study. Gastrointest Endosc 2011; 73: 963-970
18. Cotton PB, Garrow DA, Gallagher J et al. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc 2009; 70: 80-88
19. Poon RT, Yeung C, Lo CM et al. Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial. Gastrointest Endosc 1999; 49: 593-598
20. Poon RT, Yeung C, Liu CL et al. Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial. Gut 2003; 52: 1768-1773
21. Testoni PA, Bagnolo F, Andriulli A et al. Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: results of a multicenter, randomized, controlled trial. Aliment Pharmacol Ther 2001; 15: 965-972
22. Rudin D, Kiss A, Wetz RV et al. Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: meta-analysis of randomized placebo-controlled trials. J Gastroenterol Hepatol 2007; 22: 977-983
23. Arvanitidis D, Anagnostopoulos GK, Giannopoulos D et al. Can somatostatin prevent post-ERCP pancreatitis? Results of a randomized controlled trial J Gastroenterol Hepatol 2004; 19: 278-282
24. Bordas JM, Toledo V, Mondelo F et al. Prevention of pancreatic reactions by bolus somatostatin administration in patients undergoing endoscopic retrograde cholangio-pancreatography and endoscopic sphincterotomy. Horm Res 1988; 29: 106-108
25. Testoni PA, Masci E, Bagnolo F et al. Endoscopic papillo-sphincterotomy: prevention of pancreatic reaction by somatostatin. Ital J Gastroenterol 1988; 20: 70-73
26. Saari A, Kivilaakso E, Schroder T. The influence of somatostatin on pancreatic irritation after pancreatography. An experimental and clinical study. Surg Res Comm 1988; 24: 271-278
27. Deschner K, Kalloo A, Collen M et al. Somatostatin: an evaluation of its utility as adjunctive medication for ERCP. Gastrointest Endosc 1989; 35: A149
28. Guelrud M, Mendoza S, Viera L et al. Somatostatin prevents acute pancreatitis after pancreatic duct sphincter hydrostatic balloon dilation in patients with idiopathic recurrent pancreatitis. Gastrointest Endosc 1991; 37: 44-47
29. Persson B, Slezak P, Efendic S et al. Can somatostatin prevent injection pancreatitis after ERCP? Hepatogastroenterology 1992; 39: 259-261
30. Chan HH, Lai KH, Lin CK et al. Effect of somatostatin in the prevention of pancreatic complications after endoscopic retrograde cholangiopancreatography. J Chin Med Assoc 2008; 71: 605-609
31. Wang ZK, Yang YS, Cai FC et al. Is prophylactic somatostatin effective to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis or hyperamylasemia? A randomized, placebo-controlled pilot trial Chin Med J (Engl) 2013; 126: 2403-2408
32. Benvenuti S, Zancanella L, Piazzi L et al. Prevention of post-ERCP pancreatitis with somatostatin versus gabexate mesilate: a randomized placebo-controlled multicenter study. Dig Liv Dis 2006; 38: S15
33. Altman DG. How large a sample? In: Gore SM, Altman DG, eds. Statistics in Practice. London: British Medical Association; 1982